Ardent Moves on From Managers, Bumps Cost-Cutting Plan to $70M+

New CEO Dave Caspers and CFO Alfred Lumsdaine told investors the moves barely affected clinical operations and are intended to standardize many of the company’s processes.

• Published date: 10-08-2026 07:58 PM